|
|
|
|
|
|
|
James E. Higgins, Ph.D. Executive Vice President and Director of Biometrics, Health Decisions, Inc., Chapel Hill, North Carolina |
|
|
|
|
|
|
|
|
Karolyn Jackson, Ph.D. Clinical Pathology Laboratory, Zeneca Pharmaceuticals, Cheshire, England |
|
|
|
|
|
|
|
|
Agis Kydonieus, Ph.D. Vice President, R & D, ConvaTec, A Bristol-Myers Squibb Company, Princeton, New Jersey |
|
|
|
|
|
|
|
|
Gary D. Lightfoot Senior Vice President of Market Development, Pharmaco International Inc., Austin, Texas |
|
|
|
|
|
|
|
|
Michael C. Makoid, Ph.D. Associate Professor of Pharmaceutical Sciences, School of Pharmacy & Allied Health Professions, Creighton University, Omaha, Nebraska |
|
|
|
|
|
|
|
|
Vaila M. Marshall Senior Director of Regulatory Affairs and Clinical Quality Assurance, Pfizer Central Research, Kent, England |
|
|
|
|
|
|
|
|
J. Robert Powell, Pharm.D. International Director, Clinical Pharmacology, Glaxo-Wellcome Inc., Research Triangle Park, North Carolina |
|
|
|
|
|
|
|
|
Paul D. Rubin, Ph.D. Vice-President, Glaxo-Wellcome Inc., Research Triangle Park, North Carolina |
|
|
|
|
|
|
|
|
Martha M. Rumore, Pharm.D. Associate Professor, Pharmacy Administration, Arnold & Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, New York |
|
|
|
|
|
|
|
|
Albert J. Siemens, Ph.D. Executive Vice President, Clin Trials Research Inc., Research Triangle Park, North Carolina |
|
|
|
|
|
|
|
|
John C. Somberg, M.D. Professor of Medicine and Pharmacology, and Chief of the Division of Clinical Pharmacology and Cardiology, Finch University of Health Sciences/The Chicago Medical School, North Chicago, Illinois |
|
|
|
|
|
|
|
|
Terry R. Stouch, Ph.D. Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey |
|
|
|
|
|
|
|
|
John Thompson, M.A. Senior Advisor, CSC Index, Cambridge, Massachusetts |
|
|
|
|
|
|
|
|
John R. Vogel, Ph.D. Drug Development Consultant, John R. Vogel Associates, Inc., Oldwick, New Jersey |
|
|
|
|
|
|
|
|
Peter G. Welling, Ph.D. Vice President, Pharmacokinetics and Drug Metabolism, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan |
|
|
|
|
|